The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.127.8.1045

Approximately 100 chronic schizophrenic patients were examined for drug-induced eye changes. The lens was affected in 36 patients, the cornea in 19. There was a linear relationship between eye opacities and the total intake of drugs. Corneal opacities were also related to the intake of high doses of chlorpromazine over a short period of time. In most instances the ocular changes were irreversible. Despite heavy deposits in the anterior part of the eye, vision was unimpaired and the retina appeared to be intact.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.